Gene-edited HB4 wheat clears FDA evaluation in ‘key step’ towards commercializing GM wheat in USA

Argentine company Bioceres said on [June 27] that the U.S. Food and Drug Administration (FDA) has concluded positively an evaluation of its drought-resistant genetically modified HB4 wheat, a “key step” to commercialize it. it in the country.

HB4 wheat still needs approval from the US Department of Agriculture (USDA).

“The FDA has concluded that it has no further doubts about the safety of HB4 wheat and that it does not raise issues that would require FDA pre-marketing review or approval,” Bioceres said in a statement.

“Completion of this voluntary consultation program is a critical step toward commercial approval in the United States.”

Share this article

XLinkedInFacebookRedditBlueskyThreadsSMSEmail

The FDA assesses the food safety of new products before they enter the market, while the USDA ensures that genetically modified plants are not harmful to other crops.

[Editor’s note: This article was originally published in Portuguese and has been translated and edited for clarity.]

This is an excerpt. Read the original post here